Abstract
The gold standard in the diagnosis of autoimmune bullous diseases (AIBD) is based on direct immunofluorescence (DIF) of the perilesional skin in the appropriate clinical setting with routine histology consistent wtih an AIBD. Diagnostic modalities for epidermolysis bullosa (EB) include immunofluorescence antigenic mapping (IFM), transmission electron microscopy (TEM), and genetic mutational analysis. Of these, the most preferred is IFM. Because accurate findings for DIF, two options for EB, IFM, and TEM are dependent on obtaining the biopsy specimens from the appropriate sites, placing these in correct storage media, and properly transporting these, it is essential for the clinician to perform the ideal techniques and procedures when obtaining skin specimens for these necessary studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIBD:
-
Autoimmune bullous disease
- DIF:
-
Direct immunofluorescence
- EB:
-
Epidermolysis bullosa
- ELISA:
-
Enzyme-linked immunosorbent assay
- H&E:
-
Hematoxylin and eosin
- IFM:
-
Immunofluorescence antigenic mapping
- TEM:
-
Transmission electron microscopy
References
Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010;10:84–9.
Yiasemides E, Walton J, Marr P, et al. A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa. Am J Dermatopathol. 2006;28:387–94.
Bruckner A, Murrell D. Diagnosis of epidermolysis bullosa. http://www.uptodate.com/contents/diagnosis-of-epidermolysis-bullosa. Accessed 15 Feb 2012.
Lebe B, Gul Niflioglu G, Seyrek S, et al. Evaluation of clinical and histopathologic/direct immunofluorescence diagnosis in autoimmune vesiculobullous dermatitis: utility of direct immunofluorescence. Turk J Pathol. 2012;28:11–6.
Pohla-Gubo G, Hintner H. Direct immunofluorescence and indirect immunofluorescence for the diagnosis of autoimmune bullous disease. Dermatol Clin. 2011;29:365–72.
Intong L, Murrell D. How to take skin biopsies for epidermolysis bullosa. Dermatol Clin. 2010;28:197–200.
Vaughan Jones S, Palmer I, Bhogal B, et al. The use of Michel’s transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol. 1995;22:365–70.
Vodegel R, de Jong M, Meijer H, et al. Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol. 2004;4:10.
Fine J, Burge S. Genetic blistering diseases. In: Burns T, Breathnach S, Cox N, et al., editors. Rook’s textbook of dermatology. 8th ed. Oxford: Blackwell Science Ltd; 2010. p. 1–25.
Fine J. Hereditary epidermolysis bullosa (EB) biopsy sites. Available at: http://www.beutnerlabs.com/request/biopsy-sites. Accessed 31 Oct 2012.
Kimura S, Hirai A, Shimizu H. Epidermal vacuolation: an artifact due to injection of local anesthetics. Arch Dermatol Res. 1981;270:413–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lazo-Dizon, J.P.H., Murrell, D.F. (2015). How to Take a Skin Biopsy Correctly to Diagnose Epidermolysis Bullosa and Autoimmune Bullous Diseases. In: Murrell, D. (eds) Blistering Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-45698-9_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45697-2
Online ISBN: 978-3-662-45698-9
eBook Packages: MedicineMedicine (R0)